BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20652973)

  • 1. Hepatosplenic T cell lymphoma responsive to 2'-deoxycoformycin therapy.
    Bennett M; Matutes E; Gaulard P
    Am J Hematol; 2010 Sep; 85(9):727-9. PubMed ID: 20652973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
    Corazzelli G; Capobianco G; Russo F; Frigeri F; Aldinucci D; Pinto A
    Haematologica; 2005 Mar; 90(3):ECR14. PubMed ID: 15753055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.
    Grigg AP
    Leuk Lymphoma; 2001 Aug; 42(4):797-9. PubMed ID: 11697510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK; Marlton PV; Hawley CM; Norris D; Gill DS
    Am J Hematol; 2008 Apr; 83(4):330-3. PubMed ID: 17876769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
    Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
    Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukoencephalopathy in a patient with hepatosplenic T cell lymphoma.
    González de la Aleja J; Giménez-Mesa E; Posada IJ; Gonzalo-Martínez JF; Bustelo R; Escudero L
    Eur Neurol; 2006; 55(1):44-5. PubMed ID: 16479120
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
    Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
    Iannitto E; Minardi V; Calvaruso G; Ammatuna E; Florena AM; Mulè A; Tripodo C; Quintini G; Abbadessa V
    Eur J Haematol; 2005 Aug; 75(2):130-5. PubMed ID: 16000129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
    Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
    Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
    Geng J; Zhu MG; Ding YQ; Han HX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
    Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
    Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
    [No Abstract]   [Full Text] [Related]  

  • 15. Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma.
    Dhir A; Hill B; Waite ES; Cairo MS; Xavier AC
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28460. PubMed ID: 32860655
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.
    Travert M; Huang Y; de Leval L; Martin-Garcia N; Delfau-Larue MH; Berger F; Bosq J; Brière J; Soulier J; Macintyre E; Marafioti T; de Reyniès A; Gaulard P
    Blood; 2012 Jun; 119(24):5795-806. PubMed ID: 22510872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
    Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
    Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentostatin (Nipent) in T-cell lymphomas.
    Kurzrock R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):64-6. PubMed ID: 10877055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic T-cell lymphoma: sinusoidal localization of malignant T-cells--a case report.
    Kakkar N; Banerjee AK; Marwaha N; Deodhar SD
    Am J Hematol; 1996 Dec; 53(4):278-9. PubMed ID: 8948673
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration.
    Tamaska J; Adam E; Kozma A; Gopcsa L; Andrikovics H; Tordai A; Halm G; Bereczki L; Bagdi E; Krenacs L
    Virchows Arch; 2006 Oct; 449(4):479-83. PubMed ID: 16941150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.